After first studies reporting individual cases (44) or using qualitative methods (35) indicated the principal feasibility of MRD detection using lineage specific chimerism, Scheffold and colleagues first published evidence of the predictive value of CD34 lineage specific chimerism in AML in 2004. This evidence concerns the gene CD34 and acute myeloid leukemia.